ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,663Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1000

$1.33M Total Retail Price of All Prescriptions

Rank: 22 out of 1000

699 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 11,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,071 612 1 3
AMLODIPINE BESYLATE 712 419 2 6
LISINOPRIL 667 428 3 5
METFORMIN HCL 648 419 4 8
HYDROCHLOROTHIAZIDE 481 264 5 9
HYDROCODONE-ACETAMINOPHEN 478 246 S3 6 1
OMEPRAZOLE 448 206 7 2
CARVEDILOL 427 317 8 15
FUROSEMIDE 384 238 9 7
MELOXICAM 316 156 10 14
ATORVASTATIN CALCIUM 289 165 11 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 262 125 12 20
ATENOLOL 259 117 13 24
CRESTOR 256 155 14 30
GABAPENTIN 251 103 15 11
LEVOTHYROXINE SODIUM 246 159 16 4
HYDRALAZINE HCL 218 155 17 74
ZETIA 204 110 18 95
AMLODIPINE BESYLATE-BENAZEPRIL 201 133 19 59
TRAMADOL HCL 199 127 20 13
POTASSIUM CHLORIDE 179 114 21 10
NEXIUM 174 59 22 23
DIOVAN 169 136 23 67
CLOPIDOGREL 165 120 24 35
DIOVAN HCT 151 113 25 96
LANTUS SOLOSTAR 150 58 26 120
PROAIR HFA 144 59 27 50
DIGOXIN 144 129 27 52
WARFARIN SODIUM 144 114 27 22
CYCLOBENZAPRINE HCL 138 55 R 30 39
KLOR-CON 10 137 79 31 104
AZITHROMYCIN 134 75 32 36
TRAZODONE HCL 131 69 33 29
ADVAIR DISKUS 131 62 33 65
PANTOPRAZOLE SODIUM 129 63 35 28
NIFEDIPINE ER 129 84 35 130
PAROXETINE HCL 124 79 37 63
AMOX TR-POTASSIUM CLAVULANATE 121 58 38 125
PREDNISONE 120 49 39 42
NIASPAN 118 74 40 172
KLOR-CON M20 114 81 41 66
FLUTICASONE PROPIONATE 113 55 42 40
ALLOPURINOL 112 78 43 31
METOCLOPRAMIDE HCL 109 50 44 99
CLONIDINE HCL 107 72 45 27
PHENYTOIN SODIUM EXTENDED 106 31 46 115
NAMENDA 104 96 47 43
PLAVIX 104 84 47 49
GEMFIBROZIL 100 13 49 105
NOVOLOG FLEXPEN 98 27 50 267
FLUOXETINE HCL 98 57 50 51
VYTORIN 96 66 52 201
BYSTOLIC 92 67 53 126
GLYBURIDE 89 55 R 54 92
ATENOLOL-CHLORTHALIDONE 88 48 55 206
BENAZEPRIL HCL 88 52 55 61
LOVAZA 86 44 57 148
RANITIDINE HCL 84 68 58 37
TRIBENZOR 82 52 59 384
SINGULAIR 79 35 60 84
INSULIN SYRINGE 78 39 61 93
PEN NEEDLE 76 26 62 165
LOSARTAN POTASSIUM 74 32 63 25
SYMBICORT 73 45 64 149
METOPROLOL TARTRATE 73 39 64 19
VENTOLIN HFA 73 30 64 83
ALENDRONATE SODIUM 71 47 67 57
LIPITOR 71 48 67 170
LYRICA 70 32 69 47
ENALAPRIL MALEATE 70 26 69 58
TRAMADOL HCL-ACETAMINOPHEN 68 56 71 151
GLIPIZIDE 66 40 72 62
PRAMIPEXOLE DIHYDROCHLORIDE 66 42 72 147
ZOLPIDEM TARTRATE 66 16 72 16
IBUPROFEN 65 28 75 94
SPIRIVA 65 30 75 64
TAMSULOSIN HCL 63 45 77 33
HYDROCORTISONE 61 29 78 411
ISOSORBIDE MONONITRATE ER 61 36 78 71
CLOTRIMAZOLE-BETAMETHASONE 61 25 78 173
LEVEMIR FLEXPEN 60 15 81 205
RISPERIDONE 59 58 82 87
JANUMET 58 39 83 195
NITROFURANTOIN MONO-MACRO 58 37 83 191
ISOSORBIDE DINITRATE 58 38 83 224
TRIAMCINOLONE ACETONIDE 58 32 83 159
DONEPEZIL HCL 58 53 83 32
NAPROXEN 57 21 88 81
CITALOPRAM HBR 57 38 88 17
MONTELUKAST SODIUM 56 29 90 132
SERTRALINE HCL 56 46 90 26
CELEBREX 55 54 92 98
MICARDIS 53 41 93 324
DICLOFENAC SODIUM 50 11 94 123
METOPROLOL SUCCINATE 50 23 94 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.